SGRY
Surgery Partners, Inc.
Price Chart
Latest Quote
$14.23
-0.91 (-6.01%)
Current Price
| Previous Close | $15.14 |
| Open | $15.12 |
| Day High | $15.12 |
| Day Low | $14.15 |
| Volume | 811,132 |
Stock Information
| Shares Outstanding | 130.79M |
| Total Debt | $4.04B |
| Cash Equivalents | $182.30M |
| Revenue | $3.34B |
| Net Income | $-76.10M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $1.90B |
| EPS (TTM) | $-0.59 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $7.53B |
| Sales | $3.34B |
| Income | $-76.10M |
| Book/sh | $13.03 |
| Cash/sh | $1.39 |
| Employees | 16K |
Financial Ratios
| Quick Ratio | 1.35 |
| Current Ratio | 1.86 |
| Debt/Eq | 116.01 |
Returns & Margins
| ROA | 3.70% |
| ROE | 2.75% |
| Gross Margin | 22.83% |
| Operating Margin | 10.37% |
| Profit Margin | -2.28% |
Ownership
| Insider Ownership | 1.76% |
| Institutional Ownership | 123.32% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 22.24 |
| P/S | 0.57 |
| P/B | 1.12 |
Analyst Data
| Recommendation | buy |
| Target Price | $17.95 |
Technical Indicators
| SMA20 | $13.99 |
| SMA50 | $13.99 |
| SMA200 | $16.26 |
| RSI | 64.27 |
| ATR | 0.5279 |
| Shares Float | 54.18M |
| Short Float | 20.81% |
| Short Ratio | 8.04 |
| Volatility | 1.95 |
| Rel Volume | 1.85 |
Performance History
| Week | -2.61% |
| Month | +6.28% |
| Quarter | +20.75% |
| 6 Months | -6.25% |
| YTD | -4.65% |
| Year | -28.43% |
| 3 Years | -62.81% |
| 5 Years | -77.80% |
| 10 Years | -7.56% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $14.55 | 2,306,100 |
| 2026-06-17 | $14.23 | 868,000 |
| 2026-06-16 | $15.14 | 574,300 |
| 2026-06-15 | $15.13 | 1,794,000 |
| 2026-06-12 | $15.31 | 1,304,800 |
| 2026-06-11 | $14.94 | 1,370,800 |
| 2026-06-10 | $14.20 | 930,700 |
| 2026-06-09 | $13.96 | 828,200 |
| 2026-06-08 | $13.85 | 720,300 |
| 2026-06-05 | $13.71 | 906,200 |
| 2026-06-04 | $13.68 | 1,542,900 |
| 2026-06-03 | $13.51 | 1,412,200 |
| 2026-06-02 | $13.77 | 1,842,600 |
| 2026-06-01 | $13.22 | 2,129,400 |
| 2026-05-29 | $13.36 | 1,231,500 |
| 2026-05-28 | $13.65 | 971,900 |
| 2026-05-27 | $13.48 | 926,700 |
| 2026-05-26 | $13.45 | 1,255,100 |
| 2026-05-22 | $13.40 | 967,700 |
| 2026-05-21 | $13.28 | 1,044,800 |
| 2026-05-20 | $13.49 | 926,000 |
| 2026-05-19 | $13.69 | 1,759,100 |
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
đ° Latest News
Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks
StockStory âĸ 2026-06-19T19:08:58Z
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?
Zacks âĸ 2026-06-18T13:55:03Z
3 Reasons to Sell SGRY and 1 Stock to Buy Instead
StockStory âĸ 2026-06-16T21:13:04Z
Is HCA Healthcare Stock A Trap Or A Missed Opportunity?
Trefis âĸ 2026-06-11T23:04:19Z
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Motley Fool âĸ 2026-06-10T18:54:13Z
A Look At Surgery Partners (SGRY) Valuation After A Difficult Year For Shareholders
Simply Wall St. âĸ 2026-05-25T05:08:41Z
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
StockStory âĸ 2026-05-22T21:24:55Z
3 of Wall Streetâs Favorite Stocks Walking a Fine Line
StockStory âĸ 2026-05-19T20:44:55Z
5 Revealing Analyst Questions From Surgery Partnersâs Q1 Earnings Call
StockStory âĸ 2026-05-15T05:56:55Z
Jefferies Remains Bullish on Surgery Partners (SGRY) Post Q1
Insider Monkey âĸ 2026-05-14T16:51:33Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,543,700,000 | $2,368,700,000 | $2,095,800,000 | $1,964,400,000 |
| Cost Of Revenue | $2,543,700,000 | $2,368,700,000 | $2,095,800,000 | $1,964,400,000 |
| Total Revenue | $3,308,700,000 | $3,114,300,000 | $2,743,300,000 | $2,539,300,000 |
| Operating Revenue | $3,308,700,000 | $3,114,300,000 | $2,743,300,000 | $2,539,300,000 |
| Expenses | ||||
| Interest Expense | $272,600,000 | $201,700,000 | $193,000,000 | $234,900,000 |
| Total Expenses | $2,837,900,000 | $2,660,000,000 | $2,334,800,000 | $2,181,400,000 |
| Rent Expense Supplemental | $87,900,000 | $89,500,000 | $84,900,000 | $82,400,000 |
| Other Income Expense | $-81,300,000 | $-105,500,000 | $-80,500,000 | $-12,700,000 |
| Other Non Operating Income Expenses | $8,700,000 | $20,000,000 | $7,500,000 | $19,000,000 |
| Net Non Operating Interest Income Expense | $-272,600,000 | $-201,700,000 | $-193,000,000 | $-234,900,000 |
| Interest Expense Non Operating | $272,600,000 | $201,700,000 | $193,000,000 | $234,900,000 |
| Operating Expense | $294,200,000 | $291,300,000 | $239,000,000 | $217,000,000 |
| General And Administrative Expense | $118,200,000 | $138,700,000 | $120,900,000 | $102,200,000 |
| Other Operating Expenses | - | - | $-1,100,000 | $-2,400,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-77,900,000 | $-168,100,000 | $-11,900,000 | $-54,600,000 |
| Net Interest Income | $-272,600,000 | $-201,700,000 | $-193,000,000 | $-234,900,000 |
| Normalized Income | $17,613,400 | $-53,550,000 | $68,838,000 | $-19,736,899 |
| Net Income From Continuing And Discontinued Operation | $-77,900,000 | $-168,100,000 | $-11,900,000 | $-54,600,000 |
| Total Operating Income As Reported | $389,500,000 | $348,800,000 | $328,000,000 | $345,200,000 |
| Net Income Common Stockholders | $-77,900,000 | $-168,100,000 | $-11,900,000 | $-54,600,000 |
| Net Income | $-77,900,000 | $-168,100,000 | $-11,900,000 | $-54,600,000 |
| Net Income Including Noncontrolling Interests | $98,900,000 | $12,500,000 | $135,300,000 | $87,000,000 |
| Net Income Continuous Operations | $98,900,000 | $12,500,000 | $135,300,000 | $87,000,000 |
| Pretax Income | $116,900,000 | $147,100,000 | $135,000,000 | $110,300,000 |
| Special Income Charges | $-112,900,000 | $-145,000,000 | $-102,200,000 | $-44,200,000 |
| Earnings From Equity Interest | $22,900,000 | $19,500,000 | $14,200,000 | $12,500,000 |
| Operating Income | $470,800,000 | $454,300,000 | $408,500,000 | $357,900,000 |
| Depreciation Amortization Depletion Income Statement | $176,000,000 | $152,600,000 | $118,100,000 | $114,800,000 |
| Depreciation And Amortization In Income Statement | $176,000,000 | $152,600,000 | $118,100,000 | $114,800,000 |
| Gross Profit | $765,000,000 | $745,600,000 | $647,500,000 | $574,900,000 |
| Per Share | ||||
| Diluted EPS | $-0.61 | $-1.33 | $-0.09 | $-0.59 |
| Basic EPS | $-0.61 | $-1.33 | $-0.09 | $-0.59 |
| Other | ||||
| Tax Effect Of Unusual Items | $-17,386,600 | $-30,450,000 | $-21,462,000 | $-9,336,899 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $678,400,000 | $646,400,000 | $548,300,000 | $504,200,000 |
| Total Unusual Items | $-112,900,000 | $-145,000,000 | $-102,200,000 | $-44,200,000 |
| Total Unusual Items Excluding Goodwill | $-112,900,000 | $-145,000,000 | $-102,200,000 | $-44,200,000 |
| Reconciled Depreciation | $176,000,000 | $152,600,000 | $118,100,000 | $114,800,000 |
| EBITDA (Bullshit earnings) | $565,500,000 | $501,400,000 | $446,100,000 | $460,000,000 |
| EBIT | $389,500,000 | $348,800,000 | $328,000,000 | $345,200,000 |
| Diluted Average Shares | $127,209,000 | $126,122,000 | $125,613,000 | $91,952,000 |
| Basic Average Shares | $127,209,000 | $126,122,000 | $125,613,000 | $91,952,000 |
| Diluted NI Availto Com Stockholders | $-77,900,000 | $-168,100,000 | $-11,900,000 | $-54,600,000 |
| Minority Interests | $-176,800,000 | $-180,600,000 | $-147,200,000 | $-141,600,000 |
| Tax Provision | $18,000,000 | $134,600,000 | $-300,000 | $23,300,000 |
| Gain On Sale Of Business | $-30,400,000 | $-40,600,000 | $-14,400,000 | $-11,100,000 |
| Other Special Charges | $8,600,000 | $4,300,000 | $26,100,000 | $-14,400,000 |
| Restructuring And Mergern Acquisition | $73,900,000 | $100,100,000 | $61,700,000 | $47,500,000 |
| Selling General And Administration | $118,200,000 | $138,700,000 | $120,900,000 | $102,200,000 |
| Other Gand A | $118,200,000 | $138,700,000 | $120,900,000 | $102,200,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $0 |
| Gain On Sale Of Ppe | - | - | - | $-11,100,000 |
| Write Off | - | - | - | $0 |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,522,700,000 | $-3,324,000,000 | $-2,393,600,000 | $-2,181,200,000 |
| Total Assets | $8,119,700,000 | $7,890,000,000 | $6,876,700,000 | $6,682,100,000 |
| Total Non Current Assets | $6,969,000,000 | $6,770,600,000 | $5,981,700,000 | $5,761,100,000 |
| Other Non Current Assets | $56,800,000 | $57,500,000 | $103,300,000 | $144,200,000 |
| Goodwill And Other Intangible Assets | $5,235,600,000 | $5,113,700,000 | $4,380,800,000 | $4,179,400,000 |
| Other Intangible Assets | $41,000,000 | $45,700,000 | $54,800,000 | $42,300,000 |
| Current Assets | $1,150,700,000 | $1,119,400,000 | $895,000,000 | $921,000,000 |
| Other Current Assets | $212,000,000 | $182,400,000 | $127,500,000 | $110,400,000 |
| Inventory | $96,600,000 | $88,400,000 | $75,200,000 | $71,400,000 |
| Receivables | $602,200,000 | $579,100,000 | $496,400,000 | $456,300,000 |
| Accounts Receivable | $602,200,000 | $579,100,000 | $496,400,000 | $456,300,000 |
| Cash Cash Equivalents And Short Term Investments | $239,900,000 | $269,500,000 | $195,900,000 | $282,900,000 |
| Cash And Cash Equivalents | $239,900,000 | $269,500,000 | $195,900,000 | $282,900,000 |
| Non Current Deferred Assets | - | $0 | $89,500,000 | $91,500,000 |
| Non Current Deferred Taxes Assets | - | $0 | $89,500,000 | $91,500,000 |
| Prepaid Assets | - | - | $31,000,000 | $31,400,000 |
| Debt | ||||
| Net Debt | $3,462,300,000 | $3,100,800,000 | $2,579,200,000 | $2,338,900,000 |
| Total Debt | $4,024,800,000 | $3,703,400,000 | $3,061,600,000 | $2,929,700,000 |
| Long Term Debt And Capital Lease Obligation | $3,882,800,000 | $3,561,000,000 | $2,950,700,000 | $2,830,400,000 |
| Long Term Debt | $3,602,900,000 | $3,268,900,000 | $2,701,800,000 | $2,559,000,000 |
| Current Debt And Capital Lease Obligation | $142,000,000 | $142,400,000 | $110,900,000 | $99,300,000 |
| Current Debt | $99,300,000 | $101,400,000 | $73,300,000 | $62,800,000 |
| Other Current Borrowings | $99,300,000 | $101,400,000 | $73,300,000 | $62,800,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,592,900,000 | $4,254,800,000 | $3,514,800,000 | $3,399,200,000 |
| Total Non Current Liabilities Net Minority Interest | $3,977,400,000 | $3,630,400,000 | $2,991,800,000 | $2,905,800,000 |
| Other Non Current Liabilities | $41,200,000 | $30,200,000 | $41,100,000 | $75,400,000 |
| Non Current Deferred Liabilities | $53,400,000 | $39,200,000 | $0 | - |
| Non Current Deferred Taxes Liabilities | $53,400,000 | $39,200,000 | $0 | - |
| Current Liabilities | $615,500,000 | $624,400,000 | $523,000,000 | $493,400,000 |
| Other Current Liabilities | $4,700,000 | $24,800,000 | $23,900,000 | $52,300,000 |
| Payables And Accrued Expenses | $468,800,000 | $457,200,000 | $388,200,000 | $341,800,000 |
| Interest Payable | $19,500,000 | $13,400,000 | $17,800,000 | $19,400,000 |
| Payables | $255,300,000 | $240,500,000 | $195,700,000 | $183,500,000 |
| Other Payable | $46,600,000 | $31,800,000 | $23,900,000 | $31,900,000 |
| Accounts Payable | $208,700,000 | $208,700,000 | $171,800,000 | $151,600,000 |
| Current Deferred Liabilities | - | - | - | $3,200,000 |
| Equity | ||||
| Common Stock Equity | $1,712,900,000 | $1,789,700,000 | $1,987,200,000 | $1,998,200,000 |
| Total Equity Gross Minority Interest | $3,526,800,000 | $3,635,200,000 | $3,361,900,000 | $3,282,900,000 |
| Stockholders Equity | $1,712,900,000 | $1,789,700,000 | $1,987,200,000 | $1,998,200,000 |
| Gains Losses Not Affecting Retained Earnings | $-13,800,000 | $4,800,000 | $57,500,000 | $76,200,000 |
| Other Equity Adjustments | $-13,800,000 | $4,800,000 | $57,500,000 | $76,200,000 |
| Retained Earnings | $-815,200,000 | $-737,300,000 | $-569,200,000 | $-557,300,000 |
| Long Term Equity Investment | $234,000,000 | $215,400,000 | $184,100,000 | $190,300,000 |
| Investments In Other Ventures Under Equity Method | $234,000,000 | $215,400,000 | $184,100,000 | $190,300,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $129,321,144 | $127,109,383 | $126,593,727 | $125,960,834 |
| Share Issued | $129,321,144 | $127,109,383 | $126,593,727 | $125,960,834 |
| Tangible Book Value | $-3,522,700,000 | $-3,324,000,000 | $-2,393,600,000 | $-2,181,200,000 |
| Invested Capital | $5,415,100,000 | $5,160,000,000 | $4,762,300,000 | $4,620,000,000 |
| Working Capital | $535,200,000 | $495,000,000 | $372,000,000 | $427,600,000 |
| Capital Lease Obligations | $322,600,000 | $333,100,000 | $286,500,000 | $307,900,000 |
| Total Capitalization | $5,315,800,000 | $5,058,600,000 | $4,689,000,000 | $4,557,200,000 |
| Minority Interest | $1,813,900,000 | $1,845,500,000 | $1,374,700,000 | $1,284,700,000 |
| Additional Paid In Capital | $2,540,600,000 | $2,520,900,000 | $2,497,600,000 | $2,478,000,000 |
| Capital Stock | $1,300,000 | $1,300,000 | $1,300,000 | $1,300,000 |
| Common Stock | $1,300,000 | $1,300,000 | $1,300,000 | $1,300,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $279,900,000 | $292,100,000 | $248,900,000 | $271,400,000 |
| Current Capital Lease Obligation | $42,700,000 | $41,000,000 | $37,600,000 | $36,500,000 |
| Current Accrued Expenses | $213,500,000 | $216,700,000 | $192,500,000 | $158,300,000 |
| Investments And Advances | $234,000,000 | $215,400,000 | $184,100,000 | $190,300,000 |
| Goodwill | $5,194,600,000 | $5,068,000,000 | $4,326,000,000 | $4,137,100,000 |
| Net PPE | $1,442,600,000 | $1,384,000,000 | $1,224,000,000 | $1,155,700,000 |
| Accumulated Depreciation | $-651,200,000 | $-553,900,000 | $-454,400,000 | $-374,300,000 |
| Gross PPE | $2,093,800,000 | $1,937,900,000 | $1,678,400,000 | $1,530,000,000 |
| Construction In Progress | $49,200,000 | $54,700,000 | $24,200,000 | $58,100,000 |
| Other Properties | $1,600,600,000 | $1,462,100,000 | $1,281,700,000 | $1,173,500,000 |
| Machinery Furniture Equipment | $163,200,000 | $152,700,000 | $138,000,000 | $123,300,000 |
| Buildings And Improvements | $274,900,000 | $258,700,000 | $225,300,000 | $164,000,000 |
| Land And Improvements | $5,900,000 | $9,700,000 | $9,200,000 | $11,100,000 |
| Properties | $0 | $0 | $0 | $0 |
| Current Deferred Revenue | - | - | - | $3,200,000 |
| Investmentsin Associatesat Cost | - | - | - | - |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $195,600,000 | $209,700,000 | $205,000,000 | $78,200,000 |
| Operating Activities | ||||
| Operating Cash Flow | $274,300,000 | $300,100,000 | $293,800,000 | $158,800,000 |
| Cash Flow From Continuing Operating Activities | $274,300,000 | $300,100,000 | $293,800,000 | $158,800,000 |
| Operating Gains Losses | $30,900,000 | $43,700,000 | $27,700,000 | $24,200,000 |
| Investing Activities | ||||
| Capital Expenditure | $-78,700,000 | $-90,400,000 | $-88,800,000 | $-80,600,000 |
| Investing Cash Flow | $-246,600,000 | $-488,500,000 | $-225,600,000 | $-307,900,000 |
| Cash Flow From Continuing Investing Activities | $-246,600,000 | $-488,500,000 | $-225,600,000 | $-307,900,000 |
| Net Other Investing Changes | $-40,500,000 | $-24,800,000 | $-33,700,000 | $-11,500,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-57,300,000 | $262,000,000 | $-155,200,000 | $42,100,000 |
| Cash Flow From Continuing Financing Activities | $-57,300,000 | $262,000,000 | $-155,200,000 | $42,100,000 |
| Net Other Financing Charges | $-220,100,000 | $-188,400,000 | $-174,700,000 | $-196,600,000 |
| Issuance Of Capital Stock | - | $0 | $0 | $882,900,000 |
| Net Common Stock Issuance | - | $0 | $0 | $882,900,000 |
| Common Stock Issuance | - | $0 | $0 | $882,900,000 |
| Cash Dividends Paid | - | - | $0 | $0 |
| Preferred Stock Dividend Paid | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-1,039,800,000 | $-1,279,300,000 | $-807,100,000 | $-862,000,000 |
| Issuance Of Debt | $1,202,600,000 | $1,729,700,000 | $826,600,000 | $217,800,000 |
| Interest Paid Supplemental Data | $256,800,000 | $199,700,000 | $169,600,000 | $218,700,000 |
| Income Tax Paid Supplemental Data | $1,200,000 | $1,600,000 | $1,400,000 | $1,800,000 |
| End Cash Position | $239,900,000 | $269,500,000 | $195,900,000 | $282,900,000 |
| Beginning Cash Position | $269,500,000 | $195,900,000 | $282,900,000 | $389,900,000 |
| Changes In Cash | $-29,600,000 | $73,600,000 | $-87,000,000 | $-107,000,000 |
| Net Issuance Payments Of Debt | $162,800,000 | $450,400,000 | $19,500,000 | $-644,200,000 |
| Net Long Term Debt Issuance | $162,800,000 | $450,400,000 | $19,500,000 | $-644,200,000 |
| Long Term Debt Payments | $-1,039,800,000 | $-1,279,300,000 | $-807,100,000 | $-862,000,000 |
| Long Term Debt Issuance | $1,202,600,000 | $1,729,700,000 | $826,600,000 | $217,800,000 |
| Net Business Purchase And Sale | $-173,900,000 | $-375,900,000 | $-128,900,000 | $-228,700,000 |
| Sale Of Business | $1,500,000 | $4,600,000 | $1,400,000 | $12,800,000 |
| Purchase Of Business | $-175,400,000 | $-380,500,000 | $-130,300,000 | $-241,500,000 |
| Net PPE Purchase And Sale | $-32,200,000 | $-87,800,000 | $-63,000,000 | $-67,700,000 |
| Sale Of PPE | $46,500,000 | $2,600,000 | $25,800,000 | $12,900,000 |
| Purchase Of PPE | $-78,700,000 | $-90,400,000 | $-88,800,000 | $-80,600,000 |
| Change In Working Capital | $-110,400,000 | $-118,900,000 | $-63,500,000 | $-102,300,000 |
| Change In Other Working Capital | $-56,600,000 | $-46,800,000 | $-16,300,000 | $-67,000,000 |
| Change In Receivables | $-53,800,000 | $-72,100,000 | $-47,200,000 | $-35,300,000 |
| Changes In Account Receivables | $-53,800,000 | $-72,100,000 | $-47,200,000 | $-35,300,000 |
| Other Non Cash Items | $47,400,000 | $45,400,000 | $60,200,000 | $-5,200,000 |
| Stock Based Compensation | $14,800,000 | $33,300,000 | $17,700,000 | $18,400,000 |
| Deferred Tax | $16,700,000 | $131,500,000 | $-1,700,000 | $21,900,000 |
| Deferred Income Tax | $16,700,000 | $131,500,000 | $-1,700,000 | $21,900,000 |
| Depreciation Amortization Depletion | $176,000,000 | $152,600,000 | $118,100,000 | $114,800,000 |
| Depreciation And Amortization | $176,000,000 | $152,600,000 | $118,100,000 | $114,800,000 |
| Earnings Losses From Equity Investments | $-800,000 | $-2,000,000 | $-2,200,000 | $-1,800,000 |
| Gain Loss On Sale Of Business | $30,400,000 | $40,600,000 | $14,400,000 | $11,100,000 |
| Net Income From Continuing Operations | $98,900,000 | $12,500,000 | $135,300,000 | $87,000,000 |
| Asset Impairment Charge | - | - | - | $0 |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-06-18